Oxidative stress-mediated neurotoxicity is one of the significant molecular consequences in
the progression of neurodegenerative diseases like Parkinson's disease (PD). Although …

The development of enzyme mimetics that clear excess mitochondrial reactive oxidative
stress (ROS) could provide effective treatment for a wide variety of diseases. Herein …

Disordered reactive oxygen/nitrogen species are a common occurrence in various diseases,
which usually cause cellular oxidative damage and inflammation. Despite the wide range of …

Nanozymes, nanomaterials with intrinsic enzyme mimetic activity, have emerged and been
used in a broad range of applications yet are constrained with limited catalytic efficiency …

Parkinson's disease (PD), as the second most common neurodegenerative disease after
Alzheimer's, has become intractable with the increasing aging global population. The …

Reactive oxygen species (ROS), in moderate amounts, play an essential role in regulating
different physiological functions in organisms. However, increased amounts of ROS may …

Oxidative stress is associated with many acute and chronic inflammatory diseases.
Development of nanomaterial-based enzyme mimetics for reactive oxygen species (ROS) …

Glial cell‐dominated inflammatory microenvironment and neuronal damage due to oxidative
stress are major impediments to the treatment of central nervous degenerative diseases …

Artificial enzymes to mimic the endogenous antioxidant system are promising candidates for
treating and manipulating the in vivo dysregulated redox homeostasis. Though progresses …

The potentiality of nano‐enzymes in therapeutic use has directed contemporary research to
develop a substitute for natural enzymes, which are suffering from several disadvantages …